[PTGX] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
06-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 67.79%
YoY- 31.89%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 11,674 10,781 11,282 8,781 0 0 0 -
PBT -8,663 -7,661 -3,052 -4,825 -14,979 -14,101 -11,248 -16.01%
Tax 0 0 -117 -108 0 0 -75 -
NP -8,663 -7,661 -3,052 -4,825 -14,979 -14,101 -11,248 -16.01%
Tax Rate - - - - - - - -
Total Cost 20,337 18,442 14,334 13,606 14,979 14,101 11,248 48.57%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -74.21 -71.06 -27.05 -54.95 0.00 0.00 0.00 -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.41 -0.36 -0.15 -0.29 -0.89 -0.84 -0.67 -27.98%
EPS Diluted -0.41 -0.36 -0.15 -0.29 -0.89 -0.84 -0.67 -27.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.